CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- 4 Open-market sale Chief Operating Officer sold 2,191 shares at $151.21 ($331,301)
- 4 Open-market sale Director sold 20,000 shares at an average $154.61 ($3,092,278)
- 4 Planned sale Director sold 25,000 shares at an average $156.88 ($3,921,940)
- 4 Shares withheld for taxes Chief Executive Officer gave up 1,248 shares (to pay taxes)
- 4 Shares withheld for taxes CFO gave up 412 shares (to pay taxes)
- 4 Open-market sale Director sold 29,111 shares at an average $120.52 ($3,508,389)
- 4 Grant or award CHIEF ACCOUNTING OFFICER acquired 4,142 shares (grant or award)
- 4 Shares withheld for taxes Chief Executive Officer gave up 2,506 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 1,800 shares at $112.13 ($201,830)
- 4 Grant or award Director acquired 973 shares (grant or award)
- 4 Grant or award Director acquired 973 shares (grant or award)
- 4 Grant or award Director acquired 973 shares (grant or award)
- 4 Grant or award Director acquired 973 shares (grant or award)
- 4 Grant or award Director acquired 973 shares (grant or award)
- 4 Grant or award Director acquired 973 shares (grant or award)
- 4 Grant or award Director acquired 973 shares (grant or award)
- 4 Grant or award Director acquired 973 shares (grant or award)
- 4 Planned sale Director sold 26,447 shares at an average $123.71 ($3,271,688)
- 4 Shares withheld for taxes Chief Operating Officer gave up 454 shares (to pay taxes)
Page 3 of 34 · 669 filings